Scholarlink

<p>The Covid-19 pandemic resulted in a significant, acute declines in medical services nationwide, limiting patient access to care. This study used the Part B Physician and other Practitioner Payment database to track nationwide changes in dermatology service (new and return visits) among Medicare fee-for-service (FFS) beneficiaries from 2019 to 2023, analyzing recovery across states and stratified by practice size. Nationwide dermatology service volume, normalized against the number of Medicare FFS enrollees, sharply declined by 15.6% (<i>p</i> &lt; 0.001) from 2019 to 2020, then increased by 11.5% in 2021, 3.2% in 2022, and 5.0% in 2023 back to pre-pandemic levels. Service volume similarly declined in 2020 by 20.0%, 16.3%, 10.7% and 12.1% for solo, small, medium and large practices, although solo and small practices showed some persistent decline. Volume declined in 2020 for all but one state (AK), ranging from − 25.0% for MI to -5.17% for WY, with an average decrease of -14.3%. By 2023, 24 states had persistently lower service compared to 2019 levels. Net decline was highest for WV (-29.44%) and IA (-12.00%) and net increase was highest for AK (+ 29.90%) and WY (+ 23.94%) in the United States. Nationwide Medicare FFS dermatologic service utilization experienced a sharp but temporary decline in 2020, followed by progressive and statistically significant recovery through 2023, ultimately returning to pre-pandemic levels on a normalized, per-beneficiary basis. Continued monitoring is warranted to assess whether regional disparities persist and whether delayed care during the disruption period has long-term consequences on the management of chronic illnesses.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Recovery in dermatology service volume in the medicare fee-for-service population after covid-19 pandemic

  • 期刊论文

  • 发表日期：

    2026年7月17日

查看全文
  • Eudora Lee,
  • Bichchau Michelle Nguyen

摘要

The Covid-19 pandemic resulted in a significant, acute declines in medical services nationwide, limiting patient access to care. This study used the Part B Physician and other Practitioner Payment database to track nationwide changes in dermatology service (new and return visits) among Medicare fee-for-service (FFS) beneficiaries from 2019 to 2023, analyzing recovery across states and stratified by practice size. Nationwide dermatology service volume, normalized against the number of Medicare FFS enrollees, sharply declined by 15.6% (p < 0.001) from 2019 to 2020, then increased by 11.5% in 2021, 3.2% in 2022, and 5.0% in 2023 back to pre-pandemic levels. Service volume similarly declined in 2020 by 20.0%, 16.3%, 10.7% and 12.1% for solo, small, medium and large practices, although solo and small practices showed some persistent decline. Volume declined in 2020 for all but one state (AK), ranging from − 25.0% for MI to -5.17% for WY, with an average decrease of -14.3%. By 2023, 24 states had persistently lower service compared to 2019 levels. Net decline was highest for WV (-29.44%) and IA (-12.00%) and net increase was highest for AK (+ 29.90%) and WY (+ 23.94%) in the United States. Nationwide Medicare FFS dermatologic service utilization experienced a sharp but temporary decline in 2020, followed by progressive and statistically significant recovery through 2023, ultimately returning to pre-pandemic levels on a normalized, per-beneficiary basis. Continued monitoring is warranted to assess whether regional disparities persist and whether delayed care during the disruption period has long-term consequences on the management of chronic illnesses.